Lysoway Therapeutics vs Supernus Pharmaceuticals
Lysoway Therapeutics vs Supernus Pharmaceuticals, compared side by side on 13 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Lysoway Therapeutics is on 48/100 and Supernus Pharmaceuticals on 60/100.
Where each one leads
Lysoway Therapeutics
- funding raised: $45.0M against $17.5M
Supernus Pharmaceuticals
- our overall score: 60/100 against 48/100
At a glance
| Measure | Lysoway Therapeutics | Supernus Pharmaceuticals |
|---|---|---|
| What it is | Developing small-molecule modulators of lysosomal ion channels for neurodegenerative diseases. | Biopharmaceutical company developing and commercializing CNS disease treatments. |
| Category | Biotechnology, Pharmaceuticals, Healthcare, Neuroscience | Biotechnology, Pharmaceuticals, Healthcare, Neuroscience |
| Sells toBusiness model | B2B | B2B |
| Offering | Services | Services |
| Founded | 2021 | 2005 |
| Headquarters | Cambridge, USA | Rockville, United States |
| Status | Inactive | Active |
Size, funding and growth
| Measure | Lysoway Therapeutics | Supernus Pharmaceuticals |
|---|---|---|
| Employees | Not published | 809 |
| Total funding | $45.0M | $17.5M |
| Latest round | Series A | Series A |
| Valuation | $1.1B | Not published |
| LinkedIn followers | 1,282 | Not published |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Lysoway Therapeutics | Supernus Pharmaceuticals |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 48/100 | 60/100 |
| Traction | 38/100 | 56/100 |
| Team | Not published | 30/100 |
| Community | 15/100 | Not published |
| Search visibility | 20/100 | 15/100 |
| Quality | 68/100 | 78/100 |
| Agent readinessHow well an AI agent can read and act on the site | Not published | D (41/100) |
| Domain ratingLink authority, 0-100 | Not published | 67/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Lysoway Therapeutics | Supernus Pharmaceuticals |
|---|---|---|
| Hosting | Not detected | AWS |
| Frameworks | Not detected | Tailwind CSS, Bootstrap |
| Analytics | Not detected | Google Tag Manager |
Lysoway Therapeutics vs Supernus Pharmaceuticals: common questions
Which is better, Lysoway Therapeutics or Supernus Pharmaceuticals?
On our 0-100 score Supernus Pharmaceuticals rates higher (60/100 against 48/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 13 data points above: read the rows that match what you are buying for.
How do Lysoway Therapeutics and Supernus Pharmaceuticals compare on the numbers?
Lysoway Therapeutics leads on funding raised ($45.0M against $17.5M). Supernus Pharmaceuticals leads on our overall score (60/100 against 48/100).
Read the full Lysoway Therapeutics review and pricing or the Supernus Pharmaceuticals review and pricing. You can also browse other Lysoway Therapeutics alternatives we track.